19 May 2013
Keywords: merck, kgaa, revenues, core, eps, rocket, 4th-qtr
Article | 25 February 2008
German pharmaceutical and chemicals group Merck KGaA saw significant impact from the acquisition of Swiss biotechnology firm Serono and the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 February 2008
17 May 2013
© 2013 thepharmaletter.com